Motor behavioral and neuropathological deficits in mice deficient for normal prion protein expression

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 6, 2007, Pages 645-653

  Nazor, Karah E ^a,b   Seward, Tanya ^a   Telling, Glenn C ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Prion; PrPC neuroprotection; Spongiform degeneration

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CEREBELLAR ATAXIA; CONTROLLED STUDY; DEGENERATIVE DISEASE; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; GLIOSIS; LOCOMOTION; MOTOR COORDINATION; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; FEMALE; GENE EXPRESSION; GLIOSIS; HOMOZYGOTE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, TRANSGENIC; MOTOR ACTIVITY; MUTATION; PRION DISEASES; PRIONS; TIME FACTORS;

MUS; MUS MUSCULUS;

EID: 34249947609     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2007.04.004     Document Type: Article

References (46)

1. Lasmezas C.I., Deslys J.P., Robain O., Jaegly A., Beringue V., Peyrin J.M., Fournier J.G., Hauw J.J., Rossier J., and Dormont D. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275 (1997) 402-405
2. Collinge J., Palmer M.S., Sidle K.C.L., Gowland I., Medori R., Ironside J., and Lantos P. Transmission of fatal familial insomnia to laboratory animals (Lett.). Lancet 346 (1995) 569-570
3. Medori R., Montagna P., Tritschler H.J., LeBlanc A., Cortelli P., Tinuper P., Lugaresi E., and Gambetti P. Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology 42 (1992) 669-670
4. Nazor K.E., Kuhn F., Seward T., Green M., Zwald D., Purro M., Schmid J., Biffiger K., Power A.M., Oesch B., Raeber A.J., and Telling G.C. Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. EMBO J. 24 (2005) 2472-2480
5. Sc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1 (1994) 19-30
6. Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C., and Aguzzi A. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379 (1996) 339-343
7. Büeler H., Aguzzi A., Sailer A., Greiner R.-A., Autenried P., Aguet M., and Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 73 (1993) 1339-1347
8. Manson J.C., Clarke A.R., McBride P.A., McConnell I., and Hope J. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3 (1994) 331-340
9. Büeler H., Fischer M., Lang Y., Bluethmann H., Lipp H.-P., DeArmond S.J., Prusiner S.B., Aguet M., and Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356 (1992) 577-582
10. Manson J.C., Clarke A.R., Hooper M.L., Aitchison L., McConnell I., and Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8 (1994) 121-127
11. Sakaguchi S., Katamine S., Nishida N., Moriuchi R., Shigematsu K., Sugimoto T., Nakatani A., Kataoka Y., Houtani T., Shirabe S., Okada H., Hasegawa S., Miyamoto T., and Noda T. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380 (1996) 528-531
12. Moore R.C., Lee I.Y., Silverman G.L., Harrison P.M., Strome R., Heinrich C., Karunaratne A., Pasternak S.H., Chishti M.A., Liang Y., Mastrangelo P., Wang K., Smit A.F.A., Katamine S., Carlson G.A., Cohen F.E., Prusiner S.B., Melton D.W., Tremblay P., Hood L.E., and Westaway D. Ataxia in prion protein (PrP) deficient mice is associated with upregulation of the novel PrP-like protein doppel. J. Mol. Biol. 292 (1999) 797-817
13. Rossi D., Cozzio A., Flechsig E., Klein M.A., Rulicke T., Aguzzi A., and Weissmann C. Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J. 20 (2001) 694-702
14. Tobler I., Gaus S.E., Deboer T., Achermann P., Fischer M., Rülicke T., Moser M., Oesch B., McBride P.A., and Manson J.C. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380 (1996) 639-642
15. Brown D.R., and Besinger A. Prion protein expression and superoxide dismutase activity. Biochem. J. 334 (1998) 423-429
16. Brown D.R., Qin K., Herms J.W., Madlung A., Manson J., Strome R., Fraser P.E., Kruck T., von Bohlen A., Schulz-Schaeffer W., Giese A., Westaway D., and Kretzschmar H. The cellular prion protein binds copper in vivo. Nature 390 (1997) 684-687
17. Tremblay P., Meiner Z., Galou M., Heinrich C., Petromilli C., Lisse T., Cayetano J., Torchia M., Mobley W., Bujard H., DeArmond S.J., and Prusiner S.B. Doxycyline control of prion protein transgene expression modulates prion disease in mice. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 12580-12585
18. Mallucci G.R., Ratte S., Asante E.A., Linehan J., Gowland I., Jefferys J.G., and Collinge J. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J. 21 (2002) 202-210
19. Kuwahara C., Takeuchi A.M., Nishimura T., Haraguchi K., Kubosaki A., Matsumoto Y., Saeki K., Yokoyama T., Itohara S., and Onodera T. Prions prevent neuronal cell-line death. Nature 400 (1999) 225-226
20. Brown D.R., Schulz-Schaeffer W.J., Schmidt B., and Kretzschmar H.A. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp. Neurol. 146 (1997) 104-112
21. Bounhar Y., Zhang Y., Goodyer C.G., and LeBlanc A. Prion protein protects human neurons against Bax-mediated apoptosis. J. Biol. Chem. 276 (2001) 39145-39149
22. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J.L., Lehmann S., Launay J.M., and Kellermann O. Signal transduction through prion protein. Science 289 (2000) 1925-1928
23. Chiarini L.B., Freitas A.R., Zanata S.M., Brentani R.R., Martins V.R., and Linden R. Cellular prion protein transduces neuroprotective signals. EMBO J. 21 (2002) 3317-3326
24. Chesebro B., Trifilo M., Race R., Meade-White K., Teng C., LaCasse R., Raymond L., Favara C., Baron G., Priola S., Caughey B., Masliah E., and Oldstone M. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308 (2005) 1435-1439
25. Samaia H.B., and Brentani R.R. Can loss-of-function prion-related diseases exist?. Mol. Psychiatry 3 (1998) 196-197
26. Hsiao K.K., Scott M., Foster D., Groth D.F., DeArmond S.J., and Prusiner S.B. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250 (1990) 1587-1590
27. Telling G.C., Haga T., Torchia M., Tremblay P., DeArmond S.J., and Prusiner S.B. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev. 10 (1996) 1736-1750
28. Lledo P.-M., Tremblay P., DeArmond S.J., Prusiner S.B., and Nicoll R.A. Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2403-2407
29. Fraser H., and Dickinson A.G. The sequential development of the brain lesions of scrapie in three strains of mice. J. Comp. Pathol. 78 (1968) 301-311
30. Fraser H., and Dickinson A.G. Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J. Comp. Pathol. 83 (1973) 29-40
31. Lipp H.P., Stagliar-Bozicevic M., Fischer M., and Wolfer D.P. A 2-year longitudinal study of swimming navigation in mice devoid of the prion protein: no evidence for neurological anomalies or spatial learning impairments. Behav. Brain Res. 95 (1998) 47-54
32. Roesler R., Walz R., Quevedo J., de-Paris F., Zanata S.M., Graner E., Izquierdo I., Martins V.R., and Brentani R.R. Normal inhibitory avoidance learning and anxiety, but increased locomotor activity in mice devoid of PrP(C). Brain Res. Mol. Brain Res. 71 (1999) 349-353
33. Coitinho A.S., Roesler R., Martins V.R., Brentani R.R., and Izquierdo I. Cellular prion protein ablation impairs behavior as a function of age. NeuroReport 14 (2003) 1375-1379
34. Criado J.R., Sanchez-Alavez M., Conti B., Giacchino J.L., Wills D.N., Henriksen S.J., Race R., Manson J.C., Chesebro B., and Oldstone M.B. Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol. Dis. 19 (2005) 255-265
35. Collinge J., Whittington M.A., Sidle K.C., Smith C.J., Palmer M.S., Clarke A.R., and Jefferys J.G.R. Prion protein is necessary for normal synaptic function. Nature 370 (1994) 295-297
36. + currents. Neurosci. Lett. 209 (1996) 49-52
37. Herms J.W., Kretzschmar H.A., Titz S., and Keller B.U. Patch-clamp analysis of synaptic transmission to cerebellar Purkinje cells of prion protein knockout mice. Eur. J. Neurosci. 7 (1995) 2508-2512
38. Hilber P., and Caston J. Motor skills and motor learning in Lurcher mutant mice during aging. Neuroscience 102 (2001) 615-623
39. McFadyen M.P., Kusek G., Bolivar V.J., and Flaherty L. Differences among eight inbred strains of mice in motor ability and motor learning on a rotorod. Genes Brain Behav. 2 (2003) 214-219
40. Nadler J.J., Zou F., Huang H., Moy S.S., Lauder J., Crawley J.N., Threadgill D.W., Wright F.A., and Magnuson T.R. Large-scale gene expression differences across brain regions and inbred strains correlate with a behavioral phenotype. Genetics 174 (2006) 1229-1236
41. Hickey M.A., Gallant K., Gross G.G., Levine M.S., and Chesselet M.F. Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing. Neurobiol. Dis. 20 (2005) 1-11
42. Schilling G., Coonfield M.L., Ross C.A., and Borchelt D.R. Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model. Neurosci. Lett. 315 (2001) 149-153
43. Prusiner S.B., Groth D., Serban A., Koehler R., Foster D., Torchia M., Burton D., Yang S.-L., and DeArmond S.J. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10608-10612
44. Bronson R.T., Donahue L.R., Samples R., Kim J.H., and Naggert J.K. Mice with mutations in the mahogany gene Atrn have cerebral spongiform changes. J. Neuropathol. Exp. Neurol. 60 (2001) 724-730
45. He L., Lu X.Y., Jolly A.F., Eldridge A.G., Watson S.J., Jackson P.K., Barsh G.S., and Gunn T.M. Spongiform degeneration in mahoganoid mutant mice. Science 299 (2003) 710-712
46. Rosen G., La Porte N., Diechtiaref F.B., Pung C., Nissanov J., Gustafson C., Bertrand L., Gefen S., Fan Y., Tretiak O., Manly K., Park M., Williams A., Connolly M., Capra J., and Williams R. Informatics center for mouse genomics: the dissection of complex traits of the nervous system. Neuroinformatics 1 (2003) 327-342